Health-related quality of life with standard and curative therapies in thalassemia: A narrative literature review

被引:4
作者
Shah, Richa [1 ]
Badawy, Sherif M. [2 ,3 ,4 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Med Educ, Chicago, IL USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL USA
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave,Box 30, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
gene therapy editing; luspatercept; patient-reported outcomes; quality of life; stem cell transplant; thalassemia; STEM-CELL TRANSPLANTATION; PATIENT-REPORTED OUTCOMES; TRANSFUSION-DEPENDENT THALASSEMIA; BONE-MARROW-TRANSPLANTATION; BETA-THALASSEMIA; CHELATION-THERAPY; EQUIVALENCE; DISEASE; IMPACT; SF-36;
D O I
10.1111/nyas.15100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Health-related quality of life (HRQOL) is a patient-reported outcome that assesses the impact of a disease or illness on different domains of a patient's life. Different general and disease-specific measures can be used to evaluate HRQOL. This article aimed to summarize the evidence for HRQOL among patients with transfusion-dependent (TDT) and non-transfusion-dependent thalassemia (NTDT). We included HRQOL data related to standard therapy with blood transfusions, iron chelation, and/or luspatercept in TDT and NTDT, as well as curative therapies for TDT, including hematopoietic stem cell transplant (HSCT) and gene therapy. Patients with thalassemia had worse HRQOL scores compared to the general population, and chronic pain was seen to increase in frequency and severity over time with age. NTDT patients reported worse physical health and functioning, mental health, general health, and vitality than TDT patients. However, TDT patients reported worse pain, change in health, and social support than NTDT. Most therapies improved overall HRQOL among thalassemia patients. Deferasirox, an oral iron chelator, was associated with more HRQOL benefits compared to deferoxamine, an intravenous iron chelator. Luspatercept showed clinically meaningful improvement in physical functioning among TDT and NTDT. Furthermore, HSCT and gene therapy were associated with better physical, emotional, and mental domains scores. Health-related quality of life (HRQOL) is a patient-reported outcome that assesses the impact of a disease on different domains of a patient's life. This article summarizes the HRQOL among patients with transfusion-dependent (TDT) and non-transfusion-dependent thalassemia (NTDT). Patients with thalassemia had worse HRQOL scores compared to the general population. NTDT patients reported worse physical, mental, and general health than TDT patients. Most therapies improved overall HRQOL among thalassemia patients.image
引用
收藏
页码:50 / 62
页数:13
相关论文
共 72 条
[31]   Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: A meta-analytic review [J].
Gwaltney, Chad J. ;
Shields, Alan L. ;
Shiffman, Saul .
VALUE IN HEALTH, 2008, 11 (02) :322-333
[32]   Health-related quality of life among thalassemia patients in Bangladesh using the SF-36 questionnaire [J].
Hossain, Md Jubayer ;
Islam, Md Wahidul ;
Munni, Ummi Rukaiya ;
Gulshan, Rubaiya ;
Mukta, Sumaiya Akter ;
Miah, Md Sharif ;
Sultana, Sabia ;
Karmakar, Mousumi ;
Ferdous, Jannatul ;
Islam, Mohammad Ariful .
SCIENTIFIC REPORTS, 2023, 13 (01)
[33]   Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with beta-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures [J].
Javanbakht, Mehdi ;
Keshtkaran, Ali ;
Shabaninejad, Hossien ;
Karami, Hassan ;
Zakerinia, Maryam ;
Delavari, Sajad .
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2015, 4 (11) :733-740
[34]   Luspatercept Improves Quality of Life and Reduces Red Blood Cell Transfusion Burden in Patients with Non-TransfusionDependent ß-Thalassemia in the BEYOND Trial [J].
Kattamis, Antonis ;
Viprakasit, Vip ;
Cappellini, Maria Domenica ;
Voskaridou, Ersi ;
Piga, Antonio ;
Porter, John B. ;
Coates, Thomas D. ;
Forni, Gian Luca ;
Shetty, Jeevan K. ;
Miteva, Dimana ;
Esposito, Oriana ;
Kuo, Wen-Ling ;
Guo, Shien ;
Pelligra, Christopher ;
Lord-Bessen, Jennifer ;
Yucel, Aylin ;
Taher, Ali T. .
BLOOD, 2021, 138
[35]   Quality of Life and Related Paraclinical Factors in Iranian Patients with Transfusion-Dependent Thalassemia [J].
Khodashenas, Mehran ;
Mardi, Parham ;
Taherzadeh-Ghahfarokhi, Nooshin ;
Tavakoli-Far, Bahareh ;
Jamee, Mahnaz ;
Ghodrati, Niloofar .
JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH, 2021, 2021
[36]  
King AA, 2021, Sickle Cell Disease, P558
[37]   Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients [J].
Klonizakis, Philippos ;
Klaassen, Robert ;
Sousos, Nikolaos ;
Liakos, Aris ;
Tsapas, Apostolos ;
Vlachaki, Efthymia .
ANNALS OF HEMATOLOGY, 2017, 96 (11) :1937-1944
[38]   Quality-of-life of patients living with thalassaemia in the West Bank and Gaza [J].
Kohlbry, Pamela ;
al-Karmi, Bashar ;
Yamashita, Robert .
EASTERN MEDITERRANEAN HEALTH JOURNAL, 2023, 29 (06) :425-435
[39]   Improvement in Health-Related Quality of Life Following Treatment with Betibeglogene Autotemcel in Patients with Transfusion-Dependent ß-Thalassemia Enrolled in Phase 3 Studies [J].
Kwiatkowski, Janet L. ;
Locatelli, Franco ;
Walters, Mark C. ;
Porter, John B. ;
Hongeng, Suradej ;
Yannaki, Evangelia ;
Kulozik, Andreas E. ;
Sauer, Martin G. ;
Thrasher, Adrian J. ;
Thuret, Isabelle ;
Lal, Ashutosh ;
Guo, Ruiting ;
Colvin, Richard A. ;
Gruppioni, Katiana ;
Thompson, Alexis A. .
BLOOD, 2021, 138
[40]   Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia [J].
La Nasa, Giorgio ;
Caocci, Giovanni ;
Efficace, Fabio ;
Dessi, Carlo ;
Vacca, Adriana ;
Piras, Eugenia ;
Sanna, Marco ;
Marcias, Michela ;
Littera, Roberto ;
Carcassi, Carlo ;
Lucarelli, Guido .
BLOOD, 2013, 122 (13) :2262-2270